We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – Products

mRNA Vaccine Approvals for COVID-19 content piece image
Whitepaper

mRNA Vaccine Approvals for COVID-19

In this cell and gene therapy insights expert roundtable, a panel of four experts will answer some central questions surrounding the development of novel biotherapeutics.
CLINAM Releases Computer Modelling Study To Minimise COVID-19 Deaths content piece image
Product News

CLINAM Releases Computer Modelling Study To Minimise COVID-19 Deaths

Personalized vaccine strategies minimize deaths and case numbers in a Coronavirus wave of "Variants of Concern" when vaccine supply is limited, a modelling study from Switzerland predicts
Advancing the Development of Therapeutics Against Infectious Diseases content piece image
Whitepaper

Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Adjuvants for Immunotherapy and Vaccine Development content piece image
App Note / Case Study

Adjuvants for Immunotherapy and Vaccine Development

Download this flyer to discover various monophosphoryl lipid A (MPLA) adjuvants as well as a trehalose dibehenate and DDA adjuvant system for tuberculosis vaccines.
ProVir<sup>TM</sup>: Viral Antigen Bank content piece image
Product
Advertisement

ProVirTM: Viral Antigen Bank

The Native Antigen Company Wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards content piece image
Product News

The Native Antigen Company Wins ‘The Best COVID-19 Responder’ at OBN 2020 Awards

The Native Antigen Company, part of LGC Clinical Diagnostics and a supplier of reagents that enables research into diagnostics and vaccines for emerging and endemic infectious diseases, won ‘The Best COVID-19 Responder’ at OBN 2020 Awards.
80+ Mutants From SARS-CoV-2 Variants of Concern content piece image
Product
Advertisement

80+ Mutants From SARS-CoV-2 Variants of Concern

ACROBiosystems has accelerated the development of a series of recombinant antigens of the SARS-CoV-2 Variants of Concern, including B.1.617, accordingly to help better understand the transmissibility and infectivity of the variant.
CleanCap® AG (3' OMe) Reagent: Next-Generation mRNA Capping Technology content piece image
Product
Advertisement

CleanCap® AG (3' OMe) Reagent: Next-Generation mRNA Capping Technology

CleanCap® enables a high-yield, streamlined manufacturing process that is cell-free and highly scalable for mRNA-based therapeutic and vaccine development.
CEPI Expands Global Footprint of Its COVID- 19 Vaccine Lab Network content piece image
Product News

CEPI Expands Global Footprint of Its COVID- 19 Vaccine Lab Network

The Coalition for Epidemic Preparedness Innovations, or CEPI, will expand its centralized laboratory network, a global initiative to harmonize the assessment of COVID-19 vaccine candidates undergoing testing, to also evaluate clinical trial samples against priority Variants of Concern.
UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial content piece image
Product News

UK Diagnostic Company Collaborates With UK Com-COV Vaccine Trial

Oxford Immunotec has announced that its T-SPOT® Discovery SARS-CoV-2 kit will be used for T cell testing in the UK Com-COV trial.
Advertisement